View in EDS HTML Full Text PDF Full Text

Colon-targeted complement C5a1 receptor inhibition using pH-sensitive nanoparticles ameliorates experimental colitis.

Saved in:
Bibliographic Details
Title: Colon-targeted complement C5a1 receptor inhibition using pH-sensitive nanoparticles ameliorates experimental colitis.
Authors: Cui CS; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Lerskiatiphanich T; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Li XX; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Giri R; Mater Research Institute, Translational Research Institute, Brisbane, Queensland, Australia., Liu N; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Kumar V; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Whittaker AK; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Queensland, Australia., Han FY; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Queensland, Australia., Clark RJ; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Begun J; Mater Research Institute, Translational Research Institute, Brisbane, Queensland, Australia., Lee JD; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Woodruff TM; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
Source: British journal of pharmacology [Br J Pharmacol] 2025 Aug; Vol. 182 (16), pp. 3852-3869. Date of Electronic Publication: 2025 Apr 27.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381 (Electronic) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40288760
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Colon-targeted complement C5a<subscript>1</subscript> receptor inhibition using pH-sensitive nanoparticles ameliorates experimental colitis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cui+CS%22">Cui CS</searchLink>; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Lerskiatiphanich+T%22">Lerskiatiphanich T</searchLink>; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Li+XX%22">Li XX</searchLink>; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Giri+R%22">Giri R</searchLink>; Mater Research Institute, Translational Research Institute, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Liu+N%22">Liu N</searchLink>; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Kumar+V%22">Kumar V</searchLink>; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Whittaker+AK%22">Whittaker AK</searchLink>; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Han+FY%22">Han FY</searchLink>; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Clark+RJ%22">Clark RJ</searchLink>; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Begun+J%22">Begun J</searchLink>; Mater Research Institute, Translational Research Institute, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Lee+JD%22">Lee JD</searchLink>; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Woodruff+TM%22">Woodruff TM</searchLink>; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227502536%22">British journal of pharmacology</searchLink> [Br J Pharmacol] 2025 Aug; Vol. 182 (16), pp. 3852-3869. <i>Date of Electronic Publication: </i>2025 Apr 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7502536 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5381 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071188%22">00071188 </searchLink><i>NLM ISO Abbreviation: </i>Br J Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40288760
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/bph.70056
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3852
    Titles:
      – TitleFull: Colon-targeted complement C5a1 receptor inhibition using pH-sensitive nanoparticles ameliorates experimental colitis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cui CS
      – PersonEntity:
          Name:
            NameFull: Lerskiatiphanich T
      – PersonEntity:
          Name:
            NameFull: Li XX
      – PersonEntity:
          Name:
            NameFull: Giri R
      – PersonEntity:
          Name:
            NameFull: Liu N
      – PersonEntity:
          Name:
            NameFull: Kumar V
      – PersonEntity:
          Name:
            NameFull: Whittaker AK
      – PersonEntity:
          Name:
            NameFull: Han FY
      – PersonEntity:
          Name:
            NameFull: Clark RJ
      – PersonEntity:
          Name:
            NameFull: Begun J
      – PersonEntity:
          Name:
            NameFull: Lee JD
      – PersonEntity:
          Name:
            NameFull: Woodruff TM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2025 Aug
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5381
          Numbering:
            – Type: volume
              Value: 182
            – Type: issue
              Value: 16
          Titles:
            – TitleFull: British journal of pharmacology
              Type: main
ResultId 1